Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 317

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 317
---
)   Total outstanding, December 31, 2023   52,737   $369.98    4.47   Granted(1)   1,923,496    6.00    3.47   Exercised   (211,163)   0.05    Indefinite   Forfeited   -    -    -   Expired   -    -    -   Total outstanding, December 31, 2024(1)   1,765,070   $17.59    3.26   Total exercisable, December 31, 2024(1)   1,765,070   $17.59    3.26  

(1)Weighted average remaining contractual life calculations exclude (i) 16,652 Pre-Funded Warrants issued January 2024 that do not have a contractual expiration date, for which 0 remain outstanding at December 31, 2024 and (ii) 579,711 Pre-Funded Warrants granted September 2024 that do not have a contractual expiration date, for which 385,200 remain outstanding and are exercisable at December 31, 2024.

During the year ended December 31, 2024, the
Company received aggregate cash proceeds of $10,963 upon the exercise of 16,652 January 2024 Pre-Funded Warrants and 194,511 September
2024 Pre-Funded Warrants.

The following table summarizes the significant
assumptions used in determining the fair value of equity classified warrants on the respective grant or reclassification dates for the
years ended December 31, 2024 and 2023:

    2024  
    2023 
  
    Stock price 
    $ 7.20 – 16.80  
    $280.80 – 318.00 
  
    Exercise price 
    $ 6.90 – 25.41  
    $ 286.20 – 381.60 
  
    Risk-free interest rate 
     3.54% – 3.98% 
     4.07% – 4.40%
  
    Expected volatility 
     95.00% 
     90.00 – 105.00%